Literature DB >> 15469185

The personal impact of schizophrenia in Europe.

Graham Thornicroft1, Michele Tansella, Thomas Becker, Martin Knapp, Morven Leese, Aart Schene, José Luis Vazquez-Barquero.   

Abstract

The personal impact of schizophrenia is poorly described in the scientific literature. The European Psychiatric Services: Inputs Linked to Outcome Domains and Needs (EPSILON) study compared representative treated prevalence cohorts of patients with schizophrenia in five European countries, to assess unmet needs, impact on caregivers, quality of life, satisfaction with services, symptoms and disability. Of the 404 patients, 79% undertook no work of any kind, and 65% were single. Low quality of life was associated with: anxiety, depression, psychotic symptoms, more previous psychiatric admissions, alcohol abuse, having no reliable friends nor daily contact with family, being unemployed, and having few leisure activities. The most frequently occurring unmet needs among the patients were: daytime activities, company and intimate relationships, psychotic symptoms, psychological distress, and information. The most common worries of relatives were about the patient's health, and their own future, safety and financial position. Psychiatric services were therefore largely ineffective in managing the personal impact of schizophrenia, especially upon work, home and family life. Research, clinical practice and disability policy developments need to address a wider range of consequences of the disorder than symptoms alone.

Entities:  

Mesh:

Year:  2004        PMID: 15469185     DOI: 10.1016/s0920-9964(03)00191-9

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  40 in total

1.  The European Schizophrenia Cohort (EuroSC): a naturalistic prognostic and economic study.

Authors:  Paul E Bebbington; Matthias Angermeyer; Jean-Michel Azorin; Traolach Brugha; Reinhold Kilian; Sonia Johnson; Mondher Toumi; Asa Kornfeld
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-09       Impact factor: 4.328

2.  Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment.

Authors:  Andreas Wittorf; Georg Wiedemann; Gerhard Buchkremer; Stefan Klingberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-11-07       Impact factor: 5.270

3.  Which is A More Debilitating Disorder Schizophrenia or Dysthymia? - A Comparative Study.

Authors:  Shaunak A Ajinkya; Pradeep R Jadhav; Shruti Rajamani
Journal:  J Clin Diagn Res       Date:  2015-05-01

Review 4.  Epigenetic Factors in Schizophrenia: Mechanisms and Experimental Approaches.

Authors:  Melanie Föcking; Benjamin Doyle; Nayla Munawar; Eugene T Dillon; David Cotter; Gerard Cagney
Journal:  Mol Neuropsychiatry       Date:  2019-02-15

Review 5.  Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors.

Authors:  Alkomiet Hasan; Amanda Mitchell; Anja Schneider; Tobias Halene; Schahram Akbarian
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-02-05       Impact factor: 5.270

Review 6.  Measuring quality of life in patients with schizophrenia: an update.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  Pharmacoeconomics       Date:  2012-03       Impact factor: 4.981

7.  Test-retest reliability of two instruments for measuring public attitudes towards persons with mental illness.

Authors:  Bengt Svensson; Urban Markström; Ulrika Bejerholm; Tommy Björkman; David Brunt; Mona Eklund; Lars Hansson; Christel Leufstadius; Amanda Lundvik Gyllensten; Mikael Sandlund; Margareta Ostman
Journal:  BMC Psychiatry       Date:  2011-01-14       Impact factor: 3.630

8.  Needs and quality of life among patients with schizophrenia in five European centres: what is the impact of global functioning scores?

Authors:  Thomas Becker; Morven Leese; Silvia Krumm; Mirella Ruggeri; José Luis Vázquez-Barquero
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-08-17       Impact factor: 4.328

Review 9.  Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms.

Authors:  Elizabeth Kuipers; Philippa Garety; David Fowler; Daniel Freeman; Graham Dunn; Paul Bebbington
Journal:  Schizophr Bull       Date:  2006-08-02       Impact factor: 9.306

10.  Supported employment: randomised controlled trial.

Authors:  Louise M Howard; Margaret Heslin; Morven Leese; Paul McCrone; Christopher Rice; Manuela Jarrett; Terry Spokes; Peter Huxley; Graham Thornicroft
Journal:  Br J Psychiatry       Date:  2010-05       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.